Your browser doesn't support javascript.
Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study.
Perry, Richard J; Smith, Craig J; Roffe, Christine; Simister, Robert; Narayanamoorthi, Saravanan; Marigold, Richard; Willmot, Mark; Dixit, Anand; Hassan, Ahamad; Quinn, Terence J; Ankolekar, Sandeep; Zhang, Liqun; Banerjee, Soma; Ahmed, Urwah; Padmanabhan, Nishita; Ferdinand, Phillip; McGrane, Frances; Banaras, Azra; Marks, Isobel H; Werring, David J.
  • Perry RJ; Comprehensive Stroke Service, Box 119, National Hospital for Neurology and Neurosurgery, London, UK richard.perry2@nhs.net.
  • Smith CJ; Stroke Research Centre, UCL Queen Square Institute of Neurology, London, UK.
  • Roffe C; Manchester Centre for Clinical Neurosciences, Manchester Academic Health Science Centre, Salford, UK.
  • Simister R; Division of Cardiovascular Sciences, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
  • Narayanamoorthi S; Faculty of Medicine and Health Sciences, Keele University, Keele, Staffordshire, UK.
  • Marigold R; Stroke Service, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
  • Willmot M; Comprehensive Stroke Service, Box 119, National Hospital for Neurology and Neurosurgery, London, UK.
  • Dixit A; Stroke Research Centre, UCL Queen Square Institute of Neurology, London, UK.
  • Hassan A; Department of Stroke Medicine, Pennine Acute Hospitals NHS Trust, Greater Manchester, UK.
  • Quinn TJ; Department of Stroke Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Ankolekar S; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Zhang L; Department of Stroke Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Banerjee S; Department of Neurology, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Ahmed U; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Padmanabhan N; Stroke Service, Glasgow Royal Infirmary, Glasgow, UK.
  • Ferdinand P; Department of Neurology, King's College Hospital NHS Foundation Trust, London, UK.
  • McGrane F; Department of Neurology, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Banaras A; Stroke Centre, Imperial College Healthcare NHS Trust, London, UK.
  • Marks IH; Department of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Werring DJ; Stroke Service, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
J Neurol Neurosurg Psychiatry ; 92(3): 242-248, 2021 03.
Article in English | MEDLINE | ID: covidwho-913804
ABSTRACT

OBJECTIVE:

We set out to determine which characteristics and outcomes of stroke are associated with COVID-19.

METHODS:

This case-control study included patients admitted with stroke to 13 hospitals in England and Scotland between 9 March and 5 July 2020. We collected data on 86 strokes (81 ischaemic strokes and 5 intracerebral haemorrhages) in patients with evidence of COVID-19 at the time of stroke onset (cases). They were compared with 1384 strokes (1193 ischaemic strokes and 191 intracerebral haemorrhages) in patients admitted during the same time period who never had evidence of COVID-19 (controls). In addition, the whole group of stroke admissions, including another 37 patients who appeared to have developed COVID-19 after their stroke, were included in two logistic regression analyses examining which features were independently associated with COVID-19 status and with inpatient mortality.

RESULTS:

Cases with ischaemic stroke were more likely than ischaemic controls to occur in Asians (18.8% vs 6.7%, p<0.0002), were more likely to involve multiple large vessel occlusions (17.9% vs 8.1%, p<0.03), were more severe (median National Institutes of Health Stroke Scale score 8 vs 5, p<0.002), were associated with higher D-dimer levels (p<0.01) and were associated with more severe disability on discharge (median modified Rankin Scale score 4 vs 3, p<0.0001) and inpatient death (19.8% vs 6.9%, p<0.0001). Recurrence of stroke during the patient's admission was rare in cases and controls (2.3% vs 1.0%, NS).

CONCLUSIONS:

Our data suggest that COVID-19 may be an important modifier of the onset, characteristics and outcome of acute ischaemic stroke.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ischemic Stroke / Hemorrhagic Stroke / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: J Neurol Neurosurg Psychiatry Year: 2021 Document Type: Article Affiliation country: Jnnp-2020-324927

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ischemic Stroke / Hemorrhagic Stroke / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: J Neurol Neurosurg Psychiatry Year: 2021 Document Type: Article Affiliation country: Jnnp-2020-324927